-
Mashup Score: 0This Week in Infectious Disease, Recapped - 1 year(s) ago
Click on the slideshow images to read the full stories featured in this weekly infectious disease recap.
Source: Contagion LiveCategories: Infectious Disease, Latest HeadlinesTweet-
https://t.co/DH0OP8yMrX https://t.co/i7RYzuWKQN
-
-
Mashup Score: 0Hepatitis C Treatment Also Reduces Liver Disease and Death - 1 year(s) ago
What is the hepatitis C treatment uptake among people who inject drugs?
Source: Contagion LiveCategories: Infectious Disease, Latest HeadlinesTweet-
What is the hepatitis C treatment uptake among injection drug users? https://t.co/7n0xZZaOcB https://t.co/AncUcKkgte
-
-
Mashup Score: 1
High levels of mucosal IgA antibodies in the airways were found to protect against COVID-19 reinfection for at least 8 months.
Source: Contagion LiveCategories: Infectious Disease, Latest HeadlinesTweet-
High levels of mucosal IgA antibodies in the airways protected against COVID-19 #Omicron reinfection for at least 8 months. https://t.co/0gAJ0RhEPQ
-
-
Mashup Score: 1
Based on the Data and Safety Monitoring Board DSMB’s recommendation, the study will be discontinued.
Source: Contagion LiveCategories: Infectious Disease, Latest HeadlinesTweet-
#BreakingNews Based on the Data and Safety Monitoring Board’s recommendation, the #HIV vaccine study will be discontinued. https://t.co/5ysrZhJKXA
-
-
Mashup Score: 1Hepatitis and Obesity: Adding Insult to Injury - 1 year(s) ago
In this guest editorial, the author talks about the challenges associated with dealing with both health issues.
Source: Contagion LiveCategories: Infectious Disease, Latest HeadlinesTweet-
#ICYMI @the_liver_lady discusses dealing with both health issues. #livertwitter #hepatitis https://t.co/NAY6TqnAob
-
-
Mashup Score: 0
With these results, the company plans to submit their investigational vaccine, MRNA-1345, for regulatory approval in the first half of 2023.
Source: Contagion LiveCategories: Infectious Disease, Latest HeadlinesTweet-
#ICYMI #Moderna reported its #RSV vaccine for seniors demonstrated an efficacy of 83.7% against RSV-associated lower respiratory tract disease in its phase 3 trial. They plan to file for regulatory approval in the first half of 2023. https://t.co/7yVh7ID5ik
-
-
Mashup Score: 8
Preclinical testing suggests that a newly developed SARS-CoV-2 vaccine could protect against current and future variants.
Source: Contagion LiveCategories: Infectious Disease, Latest HeadlinesTweet-
Investigators have conducted preclinical testing of a possible “universal” SARS-CoV-2 vaccine for current and future variants. #IDtwitter #medtwitter https://t.co/GUEw1y9neq https://t.co/u208xRR8Np
-
-
Mashup Score: 0FDA Fast Tracks Intranasal RSV Vaccine - 1 year(s) ago
This live-attenuated investigational vaccine was developed by Codagenix, which uses its codon de-optimization platform for its candidates.
Source: Contagion LiveCategories: Infectious Disease, Latest HeadlinesTweet-
The #FDA fast-tracked a live-attenuated investigational #RSV vaccine that was developed by @Codagenix CEO J. Robert Coleman discusses the platform and the clinical trials for this vaccine as well as its investigational #COVID19 vaccine. https://t.co/XrSXVqAoFo
-
-
Mashup Score: 0An Exciting Time in CDI: Approvals, Approaches and Anticipation - 1 year(s) ago
The therapies for Clostridioides difficile infection (CDI) saw many developments in recent months and there are more exciting things to come.
Source: Contagion LiveCategories: Infectious Disease, Latest HeadlinesTweet-
The therapies for Clostridioides difficile infection #CDI saw many developments in recent months and there are more exciting things to come. #IDTwitter #MedTwitter https://t.co/84dHQTR3np
-
-
Mashup Score: 0COVID-19 Vaccination May Reduce Hepatitis B Surface Antigen - 1 year(s) ago
Some chronic hepatitis B patients experienced a dramatic decrease in hepatitis B surface antigen (HBsAg) after receiving a COVID-19 vaccine. Could there be a correlation?
Source: Contagion LiveCategories: Infectious Disease, Latest HeadlinesTweet-
Some chronic hepatitis B (#HBV) patients experienced a dramatic decrease in hepatitis B surface antigen (HBsAg) after receiving a COVID-19 vaccine. Could there be a correlation? https://t.co/S9WXfwhyKn
-
https://t.co/DH0OP8yMrX https://t.co/LfykNat6dE